Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)

Stroke ◽

10.1161/strokeaha.117.016720 ◽

2017 ◽

Vol 48 (6) ◽

pp. 1608-1616 ◽

Author(s):

Andrew D. Barreto ◽

Gary A. Ford ◽

Loren Shen ◽

Claudia Pedroza ◽

Jon Tyson ◽

...

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Multicenter Trial ◽

Tissue Plasminogen

Download Full-text

Response by Barreto and Grotta to Letter Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)”

Stroke ◽

10.1161/strokeaha.117.018294 ◽

2017 ◽

Vol 48 (9) ◽

Author(s):

Andrew D. Barreto ◽

James C. Grotta

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Multicenter Trial ◽

Tissue Plasminogen

Download Full-text

Letter by Shah Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)”

Stroke ◽

10.1161/strokeaha.117.018121 ◽

2017 ◽

Vol 48 (9) ◽

Author(s):

Nirav H. Shah

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Multicenter Trial ◽

Tissue Plasminogen

Download Full-text

Recombinant Tissue Plasminogen Activator Versus Urokinase for Local Thrombolysis of Femoropopliteal Occlusions:A Prospective, Randomized Multicenter Trial

Journal of Endovascular Therapy ◽

10.1583/1545-1550(2001)008<0638:rtpavu>2.0.co;2 ◽

2001 ◽

Vol 8 (6) ◽

pp. 638-647 ◽

Author(s):

Felix Mahler ◽

Ernst Schneider ◽

Hans Hess

Keyword(s):

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Multicenter Trial ◽

Local Thrombolysis ◽

Tissue Plasminogen

Download Full-text

Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?

Neurological Research ◽

10.1179/174313209x444044 ◽

2009 ◽

Vol 31 (4) ◽

pp. 355-361 ◽

Author(s):

Li Ma ◽

Pei-Yi Gao ◽

Yan Lin ◽

Jing Xue ◽

Xiao-Chun Wang ◽

...

Keyword(s):

Magnetic Resonance ◽

Magnetic Resonance Angiography ◽

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Stroke Patients ◽

Tissue Plasminogen

Download Full-text

Intracerebral Hemorrhage and Infarction Volume Following Recombinant Tissue Plasminogen Activator in an Acute Stroke Model

Thrombolytic Therapy in Acute Ischemic Stroke ◽

10.1007/978-3-642-76439-4_37 ◽

1991 ◽

pp. 259-261

Author(s):

G. J. del Zoppo ◽

K. E. Anderchek ◽

J. A. Koziol ◽

B. R. Copeland ◽

W. Hacke

Keyword(s):

Intracerebral Hemorrhage ◽

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Stroke Model ◽

Infarction Volume ◽

Tissue Plasminogen

Download Full-text

Intravenous Recombinant Tissue Plasminogen Activator in Acute Stroke

Thrombolytic Therapy in Acute Ischemic Stroke ◽

10.1007/978-3-642-76439-4_19 ◽

1991 ◽

pp. 161-167 ◽

Author(s):

R. von Kummer ◽

M. Forsting ◽

K. Sartor ◽

W. Hacke

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Tissue Plasminogen

Download Full-text

The Relevance of CT Scanning and Angiography for Patients with Acute Stroke Treated with Recombinant Tissue Plasminogen Activator

Thrombolytic Therapy in Acute Ischemic Stroke II ◽

10.1007/978-3-642-78061-5_26 ◽

1993 ◽

pp. 189-191

Author(s):

S. M. Wolpert ◽

M. S. Pessin

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Ct Scanning ◽

Recombinant Tissue Plasminogen Activator ◽

Tissue Plasminogen

Download Full-text

Controversies in cerebrovascular disease: high or low doses of recombinant tissue plasminogen activator to treat acute stroke? A literature review

Neurología (English Edition) ◽

10.1016/j.nrleng.2018.04.002 ◽

2020 ◽

Author(s):

V. Montalván Ayala ◽

Z. Rojas Cheje ◽

R. Aldave Salazar

Keyword(s):

Literature Review ◽

Cerebrovascular Disease ◽

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Low Doses ◽

Tissue Plasminogen

Download Full-text

Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

Cerebrovascular Diseases Extra ◽

10.1159/000348552 ◽

2013 ◽

Vol 3 (1) ◽

pp. 35-45 ◽

Author(s):

Junya Aoki ◽

Kazumi Kimura ◽

Kensaku Shibazaki ◽

Yuki Sakamoto

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Intravenous Thrombolysis ◽

Recombinant Tissue Plasminogen Activator ◽

Inversion Recovery ◽

Stroke Patients ◽

Tissue Plasminogen ◽

Fluid Attenuated Inversion Recovery

Download Full-text

Evaluation of the recombinant tissue plasminogen activator pretreatment in acute stroke patients with large vessel occlusions treated with the direct bridging approach. Is it worth the effort?

European Journal of Neurology ◽

10.1111/ene.12569 ◽

2014 ◽

Vol 22 (2) ◽

pp. 322-327 ◽

Author(s):

L. Fjetland ◽

K. D. Kurz ◽

S. Roy ◽

M. W. Kurz

Keyword(s):

Acute Stroke ◽

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Recombinant Tissue Plasminogen Activator ◽

Large Vessel ◽

Stroke Patients ◽

Tissue Plasminogen

Download Full-text